Jiexi Li

Also affiliated with Jilin University, Affiliated Hospital of Qingdao University, Heilongjiang Bayi Agricultural University, Guangzhou Medical University

Biochemistry, Genetics and Molecular BiologyMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer”.

Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1352

N/A

0DataRank · unranked

112 citations

Li Cai, Xin Lü, Xin Liang, Jiexi Li, Peiwen Chen +17 more

CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2

Cancer Research(2022)10.1158/0008-5472.can-22-0631

N/A

0DataRank · unranked

11 citations

Yin Wang, Kevin Lin, Varadha Balaji Venkadakrishnan, Martin Bakht, Wei Shi +16 more

Alternative splicing of GSDMB modulates killer lymphocyte–triggered pyroptosis

Science Immunology(2023)10.1126/sciimmunol.adg3196

N/A

0DataRank · unranked

89 citations

Shiyu Xia, Xingxin Pan, Kaixiong Ye, Zhouyihan Li, Jiexi Li +9 more

Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies

Science Translational Medicine(2023)10.1126/scitranslmed.adf6724

N/A

0DataRank · unranked

70 citations

Yin Wang, Yuehui Zhao, Justin J. Kim, Jiexi Li, Chenling Meng +9 more

CHD1, a multifaceted epigenetic remodeler in prostate cancer

Frontiers in Oncology(2023)10.3389/fonc.2023.1123362

N/A

0DataRank · unranked

28 citations

Loraine Gigi, Di Zhao, Jiexi Li

CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors

Nature Cancer(2025)10.1038/s43018-025-00952-z

N/A

0DataRank · unranked

11 citations

Jiexi Li, Yin Wang, Ximing Tang, Kevin Lin, Qidong Li +16 more